WELLS FARGO & COMPANY/MN
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in ZNTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$203,204
+$203,202 QoQ
Shares Held
41,898
+4189700.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 114 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Derivatives in ZNTL
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$16,860
PutShares
600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ZNTL ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ZNTL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $203,204 | 41,898 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2 | 1 | Shares | Defined | 2026-05-11 | |
| 2025-06-30 | $2,641 | 2,278 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $56,233 | 35,367 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $104,865 | 34,609 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $100,478 | 27,304 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $114,830 | 28,076 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $316,476 | 20,081 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $279,456 | 18,446 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,008,635 | 50,281 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,842,139 | 65,301 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $804,218 | 46,757 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $63,157 | 3,136 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $122,788 | 5,669 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,306,170 | 46,483 | Shares | Defined | 2022-08-12 | |
| 2022-06-30 | $16,860 | 600 | Put | Defined | 2022-08-12 | |
| 2022-03-31 | $5,925,204 | 128,418 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,926,116 | 129,980 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $33,035,510 | 495,731 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,982,825 | 507,196 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $167,354 | 3,857 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $875,967 | 16,865 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $276,230 | 8,450 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $251,864 | 5,245 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||